Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

Hepatology

Volumn 27, Issue 1, 1998, Pages 128-133

  Weltman, M D ^a   Farrell, G C ^a   Hall, P ^a   Ingelman Sundberg, M ^a   Liddle, C ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

ACINAR CELL; ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; HEPATITIS; HUMAN; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER HISTOLOGY; MALE; PATHOGENESIS; PRIORITY JOURNAL; STEATORRHEA;

EID: 0031962151     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270121     Document Type: Article

References (33)

1. 1 Burt AD, MacSween RNM, Peters TJ, Simpson KJ. Non‐alcoholic fatty liver: causes and complications. In: McIntyre N, et al., eds. Oxford Textbok of Clinical Hepatology. Vol 2, Ed 1. Oxford: Oxford University Press, 1991: 865–871.
2. 2 Zimmerman HJ, Ishak KG. Non‐alcoholic steatohepatitis and other forms of pseudoalcoholic liver disease. In: Hall P, ed. Alcoholic Liver Disease: Pathology and Pathogenesis. 2nd ed. London: Edward Arnold. 1994 ; 175–198.
3. 3 Bacon BR, Farahvash MJ, Janney CG, Neuschwander‐Tetri BA. Non‐alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994 ; 107: 1103–1109. MEDLINE
4. 4 Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of non‐alcoholic steatohepatitis: a follow‐up study of forty‐two patients for up to 21 years. Hepatology 1990 ; 11: 74–80. MEDLINE
5. 5 Fiatarone JR, Coverdale SA, Batey RG, Farrell GC. Non‐alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. J Gastroenterol Hepatol 1991 ; 6: 585–590. MEDLINE
6. 6 Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990 ; 12: 1106–1110. MEDLINE
7. 7 Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, et al. Ursodeoxycholic acid or clofibrate in the treatment of non–alcohol‐induced steatohepatitis: a pilot study. Hepatology 1996 ; 23: 1464–1467. MEDLINE
8. 8 Ludwig J, Viggiano TR, McGill DB, Ott BJ. Non‐alcoholic steatohepatitis. Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc 1980 ; 55: 434–438. MEDLINE
9. 9 Eriksson S, Eriksson KF, Bondesson L. Non‐alcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986 ; 220: 83–88. MEDLINE
10. 10 Itoh S, Yougel T, Kawagoe K. Comparison between non‐alcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987 ; 82: 650–654. MEDLINE
11. 11 Ingelman‐Sundberg M, Ekström G, Tindberg N. Lipid peroxidation dependent on ethanol‐inducible cytochrome P‐450 from rat liver. Adv Biophys 1988 ; 71: 43–47.
12. 12 Takahashi T, Lasker JM, Rosman AS, Lieber CS. Induction of cytochrome P‐4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993 ; 17: 236–245. MEDLINE
13. 13 Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS. The intralobular distribution of ethanol‐inducible P450IIE1 in rat and human liver. Hepatology 1989 ; 10: 437–446. MEDLINE
14. 14 Ingelman‐Sundberg M, Johansson I, Yin H, Terelius Y, Eliasson E, Clot P, Albano E. Ethanol‐inducible cytochrome P450 2E1: genetic polymorphism, regulation and possible role in the etiology of alcohol‐induced liver disease. Alcohol 1993 ; 10: 447–452. MEDLINE
15. 15 Persson JO, Terelius Y, Ingelman‐Sundberg M. Cytochrome P450 dependent formation of reactive oxygen radicals: isoenzyme‐specific inhibition of P450 mediated reduction of oxygen and carbon tetrachloride. Xenobiotica 1990 ; 20: 887–900. MEDLINE
16. 16 Ekström G, Ingelman‐Sundberg M. Rat liver microsomal NADPH‐supported oxidase activity and lipid peroxidation dependent on ethanol‐inducible cytochrome P‐450 (P‐450IIE1). Biochem Pharmacol 1989 ; 38: 1313–1319. MEDLINE
17. 17 Dai Y, Rashba‐Step J, Cederbaum AI. Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and the production of reactive oxygen intermediates. Biochemistry 1993 ; 32: 6928–6937. MEDLINE
18. 18 Gorsky LD, Koop DR, Coon MJ. On the stoichiometry of the oxidase and monoxygenase reactions catalysed by liver microsomal cytochrome P450. J Biol Chem 1984 ; 259: 6812–6817. MEDLINE
19. 19 Koop DR. Oxidative and reductive metabolism by cytochrome P‐450 2E1. FASEB J 1992 ; 6: 724–730. MEDLINE
20. 20 Bühler R, Lindros KO, von Boguslawsky K, Kärkkäinen P, Mäkinen J, Ingelman‐Sundberg M. Perivenous expression of ethanol‐inducible cytochrome P450IIE1 in livers from alcoholics and ethanol‐fed rats. Alcohol Alcohol 1991 ; 1: 311–315.
21. 21 Favreau LV, Malchoff DM, Mole JE, Schenkman JB. Responses to insulin by two forms of rat hepatic microsomal cytochrome P‐450 that undergo major (RLM6) and minor (RLM5b) elevations in diabetics. J Biol Chem 1987 ; 262: 14319–14326. MEDLINE
22. 22 Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB. Induction of cytochrome P450IIE1 in the obese overfed rat. Mol Pharmacol 1991 ; 39: 275–280. MEDLINE
23. 23 Dong Z, Hong J, Ma Q, Li D, Bullock J, Gonzalez FJ, Park SS, et al. Mechanism of induction of cytochrome P450 ac (P450j) in chemically‐induced and spontaneously diabetic rats. Arch Biochem Biophys 1988 ; 263: 29–35. MEDLINE
24. 24 Shaw PM, Barnes TS, Cameron D, Engeset J, Melvin WT, Omar G, Petrie JC, et al. Purification and characterization of an anti‐convulsant–induced human cytochrome P‐450 catalysing cyclosporin metabolism. Biochem J 1989 ; 263: 653–663. MEDLINE
25. 25 Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat model of hepatic steatosis with inflammation. Gastroenterology 1996 ; 111: 1645–1653. MEDLINE
26. 26 Ingelman‐Sundberg M, Johansson I, Penttilä KE, Glaumann H, Lindros KO. Centrilobular expression of ethanol‐inducible cytochrome P450 (IIE1) in rat liver. Biochem Biophys Res Commun 1988 ; 157: 55–60. MEDLINE
27. 27 George J, Murray M, Byth K, Farrell GC. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995 ; 21: 120–128. MEDLINE
28. 28 Morimoto M, Hajbjörk A, Wan Y‐JY, Fu PC, Clot P, Albano E, Ingelman‐Sundberg M, et al. Modulation of experimental alcohol‐induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 1995 ; 21: 1610–1617. MEDLINE
29. 29 Popper H, Lieber CS. Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 1980 ; 98: 695–716. MEDLINE
30. 30 French SW, Wong K, Albano E, Hagbjork AL, Ingelman‐Sundberg M. Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol 1993 ; 58: 61–75. MEDLINE
31. 31 Leclercq I, Horsmans Y, Desager, Pauwels S, Geubel AP. Influence of diet on liver volume and cytochrome P‐450 activities in human non‐alcoholic fatty liver [Abstract]. Hepatology 1996 ; 24: A737.
32. 32 Pinto HC, Felipe P, Bapista A, Fernandes A, Camilo E, Ramalho F, Moura MC. Hepatic steatosis and lipid peroxidation in human chronic liver diseases [Abstract]. Hepatology 1996 ; 24: A740.
33. 33 Sharer JE, Wrighton SA. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Drug Metab Dispos 1996 ; 24 (Suppl 4: 487–494. MEDLINE